Caxton Associates (UK)’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Buy
+11,535
New +$1.51M 0.03% 306
2025
Q4
Sell
-9,456
Closed -$947K 912
2025
Q3
$947K Buy
9,456
+1,508
+19% +$180K 0.02% 348
2025
Q2
$1.02M Buy
+7,948
New +$967K 0.03% 318

Other funds holding NOVT

Caxton Associates (UK)'s NOVT Position: Q1 2026 in Review

Caxton Associates (UK) opened a new position in Novanta (NOVT) in Q1 2026: 11,535 shares worth $1.36M. The stake represents 0.03% of the portfolio and ranks #306 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in NOVT as recently as Q3 2025.

Caxton Associates (UK) first reported a position in NOVT in Q2 2025 and has held it in 3 quarters since. 329 funds tracked by Wall St. Rank hold NOVT as of Q1 2026.

  • Caxton Associates (UK) held 11,535 shares of Novanta worth $1.36M as of Q1 2026.
  • Novanta was a new Caxton Associates (UK) position in Q1 2026.
  • Novanta made up 0.03% of Caxton Associates (UK)'s portfolio in Q1 2026, its #306 holding.
  • Caxton Associates (UK) first reported a position in Novanta in Q2 2025 and has held it in 3 quarters since.
  • 329 funds tracked by Wall St. Rank held Novanta as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.